ABBVIE LEADERSHIP

RICHARD A. GONZALEZ

Chairman of the Board and Chief Executive Officer

Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 25,000 people and marketing medicines in more than 170 countries. Prior to AbbVie's separation from Abbott, Mr. Gonzalez was a 30-year Abbott veteran. He served as Executive Vice President, Pharmaceutical Products Group, where he led the global pharmaceutical business, including commercial operations, research and development and manufacturing. He also served as President and Chief Operating Officer, prior to a brief retirement.


LAURA J. SCHUMACHER

Executive Vice President, Business Development, External Affairs and General Counsel

Laura Schumacher is Executive Vice President, Business Development, External Affairs and General Counsel, responsible for AbbVie's Legal, Licensing and Acquisitions, Government Affairs, Health Economics Outcomes Research, Investor Relations and Public Affairs functions. Prior to AbbVie's separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel and Secretary and had additional responsibilities for Licensing and Acquisitions, as well as the Office of Ethics and Compliance. She serves on the board of General Dynamics.


WILLIAM J. CHASE

Executive Vice President, Chief Financial Officer

Bill Chase is Executive Vice President, Chief Financial Officer. Prior to AbbVie's separation from Abbott, Mr. Chase served as Vice President, Licensing and Acquisitions. He has also served as Vice President and Treasurer, Divisional Vice President and Controller for the global pharmaceutical business.


CARLOS ALBAN

Executive Vice President, Commercial Operations

Carlos Alban is Executive Vice President, Commercial Operations. Prior to AbbVie's separation from Abbott, Mr. Alban served as Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations. He held a number of management positions in the international pharmaceutical business.


MICHAEL E. SEVERINO, M.D. 

Executive Vice President, Research & Development and Chief Scientific Officer 

Dr. Severino is the Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie. He previously served as Senior Vice President, Global Development and Corporate Chief Medical Officer at Amgen Inc. Dr. Severino held other management roles at Amgen, Inc., including Vice President, Global Development and Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development. He joined AbbVie in 2014.


TIMOTHY J. RICHMOND

Senior Vice President, Human Resources

Tim Richmond is Senior Vice President, Human Resources. Prior to AbbVie's separation from Abbott, Mr. Richmond served as Divisional Vice President, Compensation and Benefits. He also served as Divisional Vice President, Talent Acquisition.


AZITA SALEKI-GERHARDT, Ph.D.

Senior Vice President, Operations

Azita Saleki-Gerhardt is Senior Vice President, Operations. Prior to AbbVie's separation from Abbott, Dr. Saleki-Gerhardt was Vice President, Pharmaceuticals, Manufacturing and Supply.


KAREN HALE

Vice President, Chief Ethics and Compliance Officer

Karen Hale is Vice President, Chief Ethics and Compliance Officer. Prior to her current role, Ms. Hale was Vice President and Associate General Counsel, Litigation & Legal Specialty Operations.

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

EXIT ABBVIE.COM

The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.

As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to continue to this product-specific site?

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?